IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Corcept Therapeutics

CUSIP: 21835210 | 2 institutional holders

Quarters

Q1 2016Q4 2015Q3 2015Q2 2015Q1 2015
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2016

Ingalls & Snyder LLC9,078,524
2.7% of portfolio›$42.5K
StyleTurnoverLocationFiled
Ingalls & Snyder LLC
9,078,524$42.5K2.7%CoreVery LowNew York, NY2016-04-29